June 6 (Reuters) - Nordic Nanovector ASA NANOVN.OL :
* NORDIC NANOVECTOR ANNOUNCES AGREEMENT TO ACQUIRE THOR
MEDICAL,
AN EMERGING PRODUCER OF ALPHA-EMITTERS FOR RADIOPHARMACEUTICALS
TO TREAT CANCER
* NEW BOARD OF WILL EVALUATE STRATEGIC ALTERNATIVES FOR
NORDIC
NANOVECTOR'S EXISTING PIPELINE OF PATENTS IN FINANCING STRUCTURE
* COMBINED COMPANY IS EXPECTED TO HAVE FUNDING THROUGH 2025
* NORDIC NANOVECTOR WILL OWN AT LEAST 98% OF OUTSTANDING
SHARES IN
THOR MEDICAL
* NORDIC NANOVECTOR- SCATEC INNOVATION WILL BECOME LARGEST
SHAREHOLDER IN COMBINED COMPANY AFTER TRANSACTION WITH
APPROXIMATELY 24.5% OF ISSUED SHARES
* NORDIC NANOVECTOR - FORMER SHAREHOLDERS OF THOR MEDICAL
WILL OWN
50% OF COMBINED ENTITY; EXISTING NORDIC NANOVECTOR SHAREHOLDERS
WILL OWN 50%
Source text for Eikon: ID:nWkrbmzbWg
Further company coverage: NANOVN.OL
((Reuters.Briefs@thomsonreuters.com;))